ZENOVEL

As a global leader in the pharmaceutical industry, we specialize in providing comprehensive solutions for three key areas: Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and Regulatory Affairs. Our GCP services include: Risk-based monitoring in BE studies RBM in patient-based PK studies Monitoring of Phase-I, II, III trials PK-Stat and GCP consultation CRO setup for USFDA/EMA CRO upgradation GCP training SOP development Automization of trial process E-CRF, LMS, DMS support Wide therapeutic range experience Different study designs Our GMP services include: API and Formulation Plant Audit GMP consultation GAP/Root Cause Audit EUGMP/USFDA/WHO Plant Setup and Upgradation from local GMP...

Regulatory affairs,gcp,clinical research,bioequivalence ,phase-i,phase-ii,phase-iii,medical writing,scientific writing,cro audit,global audits,global monitoring,cro development,gcp training,regulatory training ,gmp training,gxp consultation,api and rld sourcing,preclinical audit,toxicology audit,glp audit,and gmp

Zenovel operates in the Pharmaceutical manufacturing industry.

Zenovel's revenue is 11m - 100m

Zenovel has 11 - 50 employees.